These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22843427)

  • 1. Pharmacological management of co-morbid conditions at the end of life: is less more?
    McLean S; Sheehy-Skeffington B; O'Leary N; O'Gorman A
    Ir J Med Sci; 2013 Mar; 182(1):107-12. PubMed ID: 22843427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing in palliative care as death approaches.
    Currow DC; Stevenson JP; Abernethy AP; Plummer J; Shelby-James TM
    J Am Geriatr Soc; 2007 Apr; 55(4):590-5. PubMed ID: 17397439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Burden of Polypharmacy in Patients Near the End of Life.
    McNeil MJ; Kamal AH; Kutner JS; Ritchie CS; Abernethy AP
    J Pain Symptom Manage; 2016 Feb; 51(2):178-83.e2. PubMed ID: 26432571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing for comorbid disease in a palliative population: focus on the use of lipid-lowering medications.
    Russell BJ; Rowett D; Abernethy AP; Currow DC
    Intern Med J; 2014 Feb; 44(2):177-84. PubMed ID: 24341863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypharmacy and the use of low or limited value medications in advanced cancer.
    Haider S; Descallar J; Moylan E; Chua W
    Intern Med J; 2021 Nov; 51(11):1891-1896. PubMed ID: 33305887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescribing in the oldest old inpatients: a retrospective analysis of patients referred for specialist geriatric consultation.
    Ilango S; Pillans P; Peel NM; Scott I; Gray LC; Hubbard RE
    Intern Med J; 2017 Sep; 47(9):1019-1025. PubMed ID: 28632340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations Between Polypharmacy, Symptom Burden, and Quality of Life in Patients with Advanced, Life-Limiting Illness.
    Schenker Y; Park SY; Jeong K; Pruskowski J; Kavalieratos D; Resick J; Abernethy A; Kutner JS
    J Gen Intern Med; 2019 Apr; 34(4):559-566. PubMed ID: 30719645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of Polypharmacy in Advanced Cancer Patients Consulted with the Palliative Service of Imam Khomeini Hospital (Tehran), Iran, 2017.
    Khaledi AR; Kazemi M; Tahmasebi M
    Asian Pac J Cancer Prev; 2019 Jan; 20(1):131-134. PubMed ID: 30678392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International prescribing patterns and polypharmacy in older people with advanced chronic kidney disease: results from the European Quality study.
    Hayward S; Hole B; Denholm R; Duncan P; Morris JE; Fraser SDS; Payne RA; Roderick P; Chesnaye NC; Wanner C; Drechsler C; Postorino M; Porto G; Szymczak M; Evans M; Dekker FW; Jager KJ; Caskey FJ;
    Nephrol Dial Transplant; 2021 Feb; 36(3):503-511. PubMed ID: 32543669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient factors associated with new prescribing of potentially inappropriate medications in multimorbid US older adults using multiple medications.
    Jungo KT; Streit S; Lauffenburger JC
    BMC Geriatr; 2021 Mar; 21(1):163. PubMed ID: 33676398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The St Vincent's potentially inappropriate medicines study: development of a disease-specific consensus list and its evaluation in ambulatory heart failure care.
    Bermingham M; Ryder M; Travers B; Edwards N; Lalor L; Kelly D; Gallagher J; O'Hanlon R; McDonald K; Ledwidge M
    Eur J Heart Fail; 2014 Aug; 16(8):915-22. PubMed ID: 25100110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypharmacy and potentially inappropriate prescriptions identified by Beers and STOPP criteria in co-morbid older patients at hospital discharge.
    Hudhra K; García-Caballos M; Casado-Fernandez E; Jucja B; Shabani D; Bueno-Cavanillas A
    J Eval Clin Pract; 2016 Apr; 22(2):189-93. PubMed ID: 26399173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choosing Wisely? Measuring the Burden of Medications in Older Adults near the End of Life: Nationwide, Longitudinal Cohort Study.
    Morin L; Vetrano DL; Rizzuto D; Calderón-Larrañaga A; Fastbom J; Johnell K
    Am J Med; 2017 Aug; 130(8):927-936.e9. PubMed ID: 28454668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Preventive Medication in Patients With Limited Life Expectancy: A Systematic Review.
    Poudel A; Yates P; Rowett D; Nissen LM
    J Pain Symptom Manage; 2017 Jun; 53(6):1097-1110.e1. PubMed ID: 28192226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is my older cancer patient on too many medications?
    Turner JP; Shakib S; Bell JS
    J Geriatr Oncol; 2017 Mar; 8(2):77-81. PubMed ID: 27840102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy.
    Hong S; Lee JH; Chun EK; Kim KI; Kim JW; Kim SH; Lee YG; Hwang IG; Kim JY; Koh SJ; Ko YH; Shin SH; Woo IS; Kim TY; Baek JY; Kim HJ; Kim HJ; Lee MA; Kwon JH; Hong YS; Ryoo HM; Kim JH
    Oncologist; 2020 Mar; 25(3):e502-e511. PubMed ID: 32162799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Prescribed Drugs Between Admission and the End of Life in Patients Admitted to Palliative Care Facilities.
    van Nordennen RT; Lavrijsen JC; Heesterbeek MJ; Bor H; Vissers KC; Koopmans RT
    J Am Med Dir Assoc; 2016 Jun; 17(6):514-8. PubMed ID: 26935532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polypharmacy patterns in the last year of life in patients with dementia.
    Denholm R; Morris R; Payne R
    Eur J Clin Pharmacol; 2019 Nov; 75(11):1583-1591. PubMed ID: 31346649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating palliative medicine into the care of persons with advanced dementia: identifying appropriate medication use.
    Holmes HM; Sachs GA; Shega JW; Hougham GW; Cox Hayley D; Dale W
    J Am Geriatr Soc; 2008 Jul; 56(7):1306-11. PubMed ID: 18482301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Missed opportunities: unnecessary medicine use in patients with lung cancer at the end of life - an international cohort study.
    Todd A; Al-Khafaji J; Akhter N; Kasim A; Quibell R; Merriman K; Holmes HM
    Br J Clin Pharmacol; 2018 Dec; 84(12):2802-2810. PubMed ID: 30187509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.